Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody variants

Antibody variants

US Patent 6632926 · Granted Oct 14, 2003

Estimated economic value: $140,037,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Methods for screening and identifying agents that inhibit or modulate the nuclea2025
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Compositions and methods for conjugating activatable antibodies2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Humanized anti-CD79B antibodies and immunoconjugates and methods of use2024
Anti-CD8 antibodies and uses thereof2023
Method of treating or delaying progression of an epidermal growth factor recepto2021
Multispecific antibodies, multispecific activatable antibodies and methods of us2021
Anti-CD79B antibodies and immunoconjugates and methods of use2021
Humanized anti-CD79b antibodies and immunoconjugates and methods of use2021
Anti-CD79b antibodies and methods of use2021